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Huntington’s disease (HD) is a debilitating, genetically inherited neurodegenerative disorder that results in early 
loss of medium spiny neurons from the striatum and subsequent degeneration of cortical and other subcortical 
brain regions. Behavioral changes manifest as a range of motor, cognitive, and neuropsychiatric impairments. 
It has been established that replacement of the degenerated medium spiny neurons with rat-derived fetal whole 
ganglionic eminence (rWGE) tissue can alleviate motor and cognitive deficits in preclinical rodent models of 
HD. However, clinical application of this cell replacement therapy requires the use of human-derived (hWGE), 
not rWGE, tissue. Despite this, little is currently known about the functional efficacy of hWGE. The aim of 
this study was to directly compare the ability of the gold standard rWGE grafts, against the clinically relevant 
hWGE grafts, on a range of behavioral tests of motor function. Lister hooded rats either remained as unop-
erated controls or received unilateral excitotoxic lesions of the lateral neostriatum. Subsets of lesioned rats 
then received transplants of either rWGE or hWGE primary fetal tissue into the lateral striatum. All rats were 
tested postlesion and postgraft on the following tests of motor function: staircase test, apomorphine-induced 
rotation, cylinder test, adjusting steps test, and vibrissae-evoked touch test. At 21 weeks postgraft, brain tissue 
was taken for histological analysis. The results revealed comparable improvements in apomorphine-induced 
rotational bias and the vibrissae test, despite larger graft volumes in the hWGE cohort. hWGE grafts, but not 
rWGE grafts, stabilized behavioral performance on the adjusting steps test. These results have implications for 
clinical application of cell replacement therapies, as well as providing a foundation for the development of stem 
cell-derived cell therapy products.
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INTRODUCTION
Huntington’s disease (HD) is a neurodegenerative dis-
ease caused by an autosomal dominant gene mutation on 
chromosome 4, which results in an aberrant expansion 
of a polyglutamine tract within the huntingtin protein. 
Medium spiny neurons of the striatum are particularly 
susceptible to the toxic impact of the intracellular aggre-
gated protein inclusions early in the course of disease 
manifestation, although neuronal cell loss eventually 
occurs throughout cortical and subcortical brain regions. 
The most overt symptoms of the disease include motor 
impairments, such as chorea and rigidity, but cognitive 
and neuropsychiatric symptoms also manifest early in 
the course of disease onset. No disease-modifying inter-
ventions are available, and current treatment options are 
restricted to pharmaceuticals that modulate only some 
specific symptoms.
Cell replacement therapies aim to repair the nervous 
system by reintroducing the cells that degenerate and 
thereby restore efferent and afferent projections between 
cortical and basal ganglia nuclei. To achieve this, the region 
from which the striatum originates in the developing brain, 
the ganglionic eminence, is dissected from the fetal brain, 
dissociated as a cell suspension, and transplanted into the 
adult host brain, where it matures into the projection neu-
rons and interneurons that comprise the striatum.
Proof of principle of the efficacy of this intervention 
has been demonstrated in preclinical rat lesion mod-
els of HD. In these studies, the whole ganglionic emi-
nence (WGE) was harvested from rat embryos at day 
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E14–15 and transplanted into the degenerated striatum 
of the adult rodent host. Long-term behavioral assess-
ment revealed improvements on tasks of fine motor 
function (13,25,37) and tests of cognitive performance 
(11). Importantly, however, these proof-of-concept stud-
ies have, almost exclusively, been conducted with rat-
derived WGE (rWGE) grafts. As a result, little is known 
regarding the ability of human-derived fetal striatal 
(hWGE) grafts to alleviate functional deficits in preclini-
cal models of HD. To date, studies reporting the intra-
striatal grafting of hWGE tissue into rodent hosts have 
predominately described morphological and immunohis-
tochemical data (17,18,29), with much less comprehen-
sive analysis of functionality (28,32).
Despite this, the safety and efficacy of transplanting 
hWGE tissue has been investigated in early phase clini-
cal trials, in which HD patients received either cell sus-
pension or diced tissue transplants. The results obtained 
from follow-up assessments administered up to 6 years 
postgraft have confirmed the safety of the procedure and 
the survival of metabolically active tissue transplants 
(14,15,20,31). Interestingly, in one safety study, three 
out of five grafted patients demonstrated long-term sta-
bilization of performance on motor and cognitive tasks 
relative to a nongrafted cohort of patients who demon-
strated a progressive deterioration of these functions. 
Moreover, signals were evident on MRI and PET scans 
that suggest surviving fetal tissue grafts and some evi-
dence of circuitry reconstruction were present (1–3,16). 
Thus, the hWGE grafts appear to at least partially alle-
viate symptoms in at least some patients, although the 
underlying cortical and subcortical neurodegeneration 
associated with the disease appears not to have been 
halted, and the observed functional improvements 
declined over 5–7 years.
Given how little is known regarding the ability of 
hWGE grafts to improve functional deficits, it is neces-
sary to establish the relationship between the “gold stan-
dard” rWGE grafts and hWGE grafts. The aim of this 
study was to determine whether hWGE grafts might be 
capable of improving motor function in a manner compa-
rable to rWGE grafts. Moreover, the tests are undertaken 
in a model involving relatively pure striatal cell loss in 
the lesioned rats, without the additional extensive corti-
cal degeneration that can compromise interpretation of 
the clinical studies. Based on the longer maturation times 
necessary for human-derived cells (18), it was hypothe-
sized that the improvement in motor function observed in 
rats receiving hWGE grafts would be delayed relative to 
rWGE grafts, which typically yield significant enhance-
ment of performance from 10 to 12 weeks posttransplant. 
Thus, in the present study, rats grafted with either rWGE 
or hWGE were tested up to 21 weeks postgraft on a bat-
tery of five tests of motor function.
MATERIALS AND METHODS
Animals
Forty-eight female Lister hooded rats (Harlan, Shardlow, 
UK) were housed in groups of four per cage and main-
tained on a 14:10-h light/dark cycle. Rats had ad lib 
access to food and water, except during staircase testing 
when rats were maintained at ~90% of their free-feeding 
weights by providing a set daily portion of laboratory 
chow. All experiments were conducted in compliance 
with the UK Animals (Scientiﬁc Procedures) Act 1986 
under Home Ofﬁce License No. 30/3036 and with the 
approval of the local Cardiff University Ethics Review 
Committee.
Experimental Design
Rats (n = 48) were pretrained on the staircase task for 
3 weeks before a subset (n = 39) of rats received unilat-
eral quinolinic acid (Sigma-Aldrich, Dorset, UK) lesions 
to the striatum. Two weeks postlesion, all rats were 
tested on the staircase task for 5 days, and baseline func-
tional impairments were also measured on the adjusting 
steps test, vibrissae test, cylinder test, and apomorphine 
(Sigma-Aldrich)-induced rotation test (see below). 
Lesioned rats were divided into three equal groups 
based on performance on the staircase and apomor-
phine-induced rotation tests. Rats then either remained 
as lesion-only controls (n = 9) or received rWGE grafts 
(n = 14) or hWGE grafts (n = 16). Commencing 4 weeks 
postlesion, daily cyclosporine (Sandoz Pharmaceutical, 
Surrey, UK) injections were initiated for all rats. Rats 
receiving rWGE or hWGE grafts underwent transplant 
surgery the following day. Testing on the staircase task 
commenced 10 weeks postgraft and continued weekly 
up to 20 weeks postgraft. Apomorphine-induced rota-
tions were undertaken at 15, 18, and 21 weeks postgraft. 
Performance on the stepping, vibrissae, and cylinder 
tests was assessed at 20 weeks postgraft. At 21 weeks 
postgraft, rats were perfused, and tissue was taken for 
immunohistochemical analyses.
Surgical Procedures
Lesions. Rats were anesthetized with isoflourane 
(2–4% with carrier gases oxygen and nitrous oxide; 
TEVA UK Ltd., Eastbourne, UK) in a stereotaxic frame. 
The lateral striatum was targeted with 4 × 0.25-µl injec-
tions of 0.12 M quinolinic acid using the following ste-
reotaxic coordinates: 1) AP −0.4, ML −3.7 (from bregma), 
DV −5.0/−4.0 (from dura) and 2) AP +1.2, ML −2.9, and 
DV −5.0/−4.0. All rats received Metacam (Boehringer 
Ingelheim, Ingelheim am Rhein, Germany) for pain relief, 
and diazepam (Hameln Pharmaceuticals, Gloucester, 
UK) was administered subcutaneously immediately after 
the surgical session.
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Transplantation of rWGE. The uterine horn was 
removed from terminally anesthetized time-mated Lister 
hooded rats by Cesarean section at embryonic day 14 
(E14) and placed into a sterile dish of Dulbecco’s modiﬁed 
Eagle medium (DMEM; Life Technologies/Thermo-
Fisher, Carlsbad, CA, USA). The brain was removed from 
each embryo, and WGEs were subsequently dissected out 
bilaterally into fresh DMEM. For cell preparation, WGEs 
were washed twice in DMEM/F12 (Life Technologies) 
then incubated at 37°C for 20 min in TrypLE Express 
(Life Technologies) containing 20 U/ml dornase alfa 
(Pulmozyme; Roche, Hertfordshire, UK). Tissue was dis-
sociated by trituration in 200 µl of DMEM/F12 to obtain 
a quasi-single-cell suspension. Cell viability was assessed 
by Trypan blue exclusion (Life Technologies) in a hemo-
cytometer and revealed that ~96% of all cells were viable.
Transplantation of hWGE. Human fetal tissue was col-
lected from medical terminations of pregnancy with full 
donor consent, through the SWIFT human fetal tissue bank 
(http://www.biobankswales.org.uk/swift-research-tissue-
bank), under UK Human Tissue Authority research license 
(No. 12457) held by Cardiff University and with ethical 
approval of the project from the Bro Taf local research 
ethics committee. Gestational age was estimated through 
ultrasound scan prior to the procedure in combination with 
measurement of fetal regions (12). The human WGE tissue 
was harvested from three fetuses with a mean (and standard 
deviation) crown–rump length of 33.6 ± 4.6 mm, which cor-
responds to approximately 10 weeks of gestation (8 weeks 
postconception). Embryos were not pooled; instead, each 
rat received tissue from one of the three donors. Tissue was 
incubated at 37°C for 20 min in TrypLE Express contain-
ing 20 U/ml dornase alfa. Tissue was dissociated by tritu-
ration in 200 µl of DMEM/D to obtain a quasi-single-cell 
suspension. The viability for each sample was estimated as 
a mean of 85.3 ± 4.9%.
For both the rWGE and hWGE grafts, each rat received 
a 2-µl suspension containing approximately 500,000 cells 
in total. Cells were implanted at a rate of 1 µl/min and 
distributed over two stereotaxic depths (−4.5, −3.7) at the 
site AP: +0.4, ML: −3.2 mm.
Behavioral Testing
All behavioral testing was conducted blind to the treat-
ment of the rats.
Apomorphine-Induced Rotations. A bank of 16 auto-
mated rotometer bowls (Rotorat; Med Associates, St. 
Albans City, VT, USA) recorded the frequency of clock-
wise and anticlockwise rotations. Apomorphine-induced 
rotations were recorded for 60 min after subcutaneous 
injection of 1.0 mg/kg apomorphine hydrochloride hemi-
hydrate (Sigma-Aldrich). Rotation scores were expressed 
as the net (ipsilateral minus contralateral) rotations over 
the test session. Rotational bias was tested postlesion and 
at 15, 18, and 21 weeks postgraft.
Cylinder Test. Forelimb asymmetry was measured 
using the cylinder test (34). Rats were placed in a clear 
Perspex cylinder, in front of a three-sided mirror (allow-
ing simultaneous all round observation of rat behavior), 
and monitored for up to 5 min while they explored the 
restricted environment until they achieved approximately 
30 paw touches. Behavior was captured via a video 
recorder, and the number of times the rat touched the side 
walls with either the ipsilateral or contralateral paw was 
counted from video images. Cylinder data were collected 
on two occasions: at 2 weeks postlesion and at 20 weeks 
posttransplantation. Data are expressed as the number of 
contralateral touches as a percentage out of the total num-
ber of touches made using both paws.
Staircase Task. Lateralized paw dexterity was mea-
sured in the staircase test (24). Rats were food restricted to 
approximately 90% of their free-feeding body weight for 
testing. The seven steps on either side of the central plinth 
were each baited with two sugar pellets (45 mg). All rats 
were pretrained on the reaching task over 15 days prior 
to surgery and then tested for lesion effects over 5 days 
at 2 weeks postlesion. Finally, rats were tested for 15 min 
each day for 50 days from 10 to 20 weeks postgraft. The 
number of successful retrievals was recorded separately for 
the ipsilateral and contralateral sides. Data are presented as 
the mean number of successful retrievals the rat made with 
its contralateral and ipsilateral paws over the final 20 days 
of testing (16–20 weeks posttransplantation).
Vibrissae-Evoked Forepaw Placing Test. In this task of 
spontaneous sensorimotor function (34,35), rats were lifted 
upward toward the edge of a table so that only the vibrissae 
would touch the table edge. An unoperated control rat will 
reflexively place its free forepaw onto the table surface as 
soon as the vibrissae contact the table surface. This test was 
performed 10 times per side during each experimental day.
Adjusting Steps Test. Forelimb akinesia was assessed 
using the adjusting steps test (27). This involved restrain-
ing one forelimb and counting the number of adjust-
ing steps made by the unrestrained forelimb when a rat 
was moved sideways along a table surface for 100 cm 
in either a medial or lateral direction with respect to the 
unrestrained paw. Stepping data were collected postle-
sion and at 21 weeks postgraft. The data presented are 
the number of adjusting steps made with the contralateral 
paw in forward and backward trajectories.
Immunohistochemical Techniques
Perfusion. Rats were terminally anesthetized with 
sodium pentobarbital (Euthatal; Merial, Woking, UK) and 
sacrificed by transcardial perfusion with 0.01 M phos-
phate buffer followed by 1.5% paraformaldehyde (pH 7.4; 
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Sigma-Aldrich). Brains were postfixed for 24 h in 1.5% 
PFA before being transferred to 25% sucrose solution. 
Tissue was sectioned on a freezing sledge microtome at 
40 µm thickness in a 1:12 series.
Bright-Field and Fluorescent Immunohistochemistry. 
Free-floating sections were blocked in 3% normal serum, 
then incubated in primary antibody with 1% serum over-
night at room temperature. Tissue was incubated in sec-
ondary antibody (1:200) with 1% serum for 3 h, then 
immersed in an avidin-biotinylated enzyme complex 
(Vector Laboratories, Peterborough, UK) for 2 h, then 
stained with either DAB or Vector SG (Vector Labs).
The primary antibodies used were DARPP-32 (human 
specific, 1:1,000; Abcam, Cambridge, UK); DARPP-32 
(1:30,000; kind gift from Cornell University), tyrosine 
hydroxylase (TH, 1:1,000; Millipore, Watford, UK), 
b-tubulin (1:500; Sigma-Aldrich, Poole, UK), NeuN 
(1:1,000; Millipore), and HuNu (1:1,000; Millipore).
Statistics
Statistical analyses were conducted using SPSS (v20; 
IBM, Armonk, NY, USA). Using analysis of variance 
(ANOVA) tests, the between-subjects factor of Group 
and within-subjects factor of Time were used. Graphical 
data are represented as means and standard error of the 
means (SEM). Newman–Keuls method was used for post 
hoc analyses. Results were deemed to be statistically sig-
nificant with a value of p < 0.05.
RESULTS
Histological Analyses
Histological analysis of the brain tissue revealed 
large lateral lesions that comprised approximately 30% 
of the right hemisphere (Fig. 1A–C) and resulted in an 
increased ventricular volume. In the graft groups, 11/14 
rWGE and 10/13 hWGE grafts survived to 21 weeks post-
transplantation. rWGE grafts (Fig. 1D) were smaller on 
average than hWGE grafts [F(1, 19) = 19.25, p < 0.001] 
(Fig. 1E, I). DARPP-32 expression was observed in all 
grafts (Fig. 1G, H, and J–L), distributed with a patchy 
staining [“P-zones” (19)]. The mean P-zone volume was 
similar between rWGE and hWGE grafts overall (F < 1, 
p = n.s.), but the proportion of P-zone (as a percentage of 
graft volume) was greater in rWGE than in hWGE grafts 
[F(1, 19) = 5.45, p < 0.05] (Fig. 1F and L). Considerable 
innervation of dopaminergic fibers was evident in both 
rWGE (Fig. 1G and J) and hWGE grafts (Fig. 1H and K). 
Thus, similar rates of survival and TH innervation were 
observed in both graft groups, although differences in 
graft volume and DARPP-32 expression were evident.
Behavioral Analyses
Apomorphine-Induced Rotations. Rotational bias 
data were analyzed by ANOVA with Time (Baseline, 
15 weeks, 18 weeks, and 21 weeks postgraft) and Group 
as factors (Fig. 2A). Unlike lesioned and grafted rats, 
control rats did not rotate at any of the time points. At 
the postlesion baseline phase, there was no difference 
between the rotational bias of Lesion, rWGE, and hWGE 
grafted rats [Time × Group: F(9, 99) = 6.39, p < 0.001; 
Effect of Group at Baseline: F(3, 33) = 28.41]. However, 
at 15, 18, and 21 weeks postgraft, rWGE and hWGE rats 
were rotating significantly less than Lesion rats [Effect 
of Group at weeks 15–21: minimum F(3, 33) = 47.49; 
Lesion vs. rWGE and hWGE rats, all p £ 0.01]. At all time 
points, rWGE and hWGE grafted rats performed compa-
rably (rWGE vs. hWGE, n.s.) and control rats differed 
significantly to all other groups [Group: F(3, 33) = 76.13, 
all p < 0.001]. Thus, rWGE and hWGE induced a compa-
rable reduction in apomorphine-induced rotational bias.
Cylinder. Analysis of the percentage of contralateral 
paw use in the cylinder test revealed no effect of Group, 
nor any differences between the postlesion and postgraft 
time points [maximum: F(3, 33) = 2.34, n.s.] (Fig. 2B).
Staircase. Data from the staircase test were analyzed 
separately for the ipsilateral and contralateral sides, with 
Group and Time (postlesion vs. postgraft) as factors 
(Fig. 2C). On the ipsilateral side, Lesion rats performed 
significantly worse than Control rats, but grafted rats 
did not differ from either the Lesion or Control groups 
[Group: F(3, 33) = 3.30, p < 0.05; Control vs. Lesion: 
p < 0.05]. On the contralateral side, Control rats performed 
significantly better than all other groups, but no differ-
ences were evident between the lesion and grafted rats 
[Group: F(3, 33) = 20.66, p < 0.001; Control vs. Lesion, 
rWGE, hWGE: all p < 0.001].
Performance improved relative to baseline for Control, 
rWGE, and hWGE rats, on both the ipsilateral and contralat-
eral paws [minimum t(9) = 2.28, p < 0.05] (Fig. 2D), except 
for Lesion rats, which did not meet conventional levels of 
significance [t(6) = 2.07, p = 0.075, and 2.15, p = 0.084, for 
the ipsilateral and contralateral sides, respectively].
FACING PAGE
Figure 1. Immunohistochemical analysis of rat- and human-derived WGE grafts at 21 weeks. Representative images of Control 
(A) and Lesion (B) brain tissue, stained with NeuN. Representative images of a rWGE graft (D) stained with NeuN and a hWGE graft 
(E) stained with HuNu. DARPP-32 staining (blue) and TH staining (brown) in a rWGE graft (G) and a hWGE graft (H). Higher mag-
nification of TH innervation in a rWGE (J) and a hWGE (K) graft. Mean percentage of lesion area, relative to the intact tissue (C) and 
mean P-zone area in mm3 for rWGE and hWGE grafts (F). Mean graft area (I) and the mean P-zone volume, as a percentage of total 
graft volume (L) for rWGE and hWGE grafts. Scale bar: 1,000 µm. Error bars: standard error of the mean (SEM).
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Vibrissae Test. Data from each side were analyzed with 
Time (postlesion, postgraft) and Group as factors. On 
the ipsilateral side, Lesion rats performed significantly 
worse than Control rats [Group: F(3, 33) = 4.00, p < 0.05; 
Control vs. Lesion, p < 0.05] (Fig. 2E), but no differences 
were observed in the grafted rats. On the contralateral 
side, Control rats performed significantly better than all 
other groups [Group: F(3, 33) = 37.38, p < 0.001; Control 
vs. Lesion, rWGE, hWGE: all p < 0.001]. Interestingly, 
however, only rWGE and hWGE grafted rats demon-
strated improved performance at the postgraft time point 
relative to their postlesion performance [Group × Time: 
F(3, 33) = 3.02, p < 0.05; Effect of Time for rWGE and 
hWGE, minimum F(1, 33) = 6.33, p < 0.05].
To explore this further, we asked to what extent postgraft 
performance had changed relative to postlesion baseline 
performance. The results reveal no change in performance 
on the ipsilateral side (all groups compared 100%, n.s.) 
(Fig. 2F). On the contralateral side, however, the perfor-
mance of rats grafted with both rWGE and hWGE sig-
nificantly improved relative to their postlesion baseline 
[t(10) = 3.02 and t(9) = 2.82, for rWGE and hWGE, respec-
tively, both p < 0.05; n.s. for Control and Lesion].
Adjusting Steps Test. Data from the ipsilateral and con-
tralateral paws were analyzed with Time (postlesion, post-
graft) and Group as factors. No effects of lesion or graft 
were evident in the forward or backward adjusting steps 
made using the ipsilateral paw (data not shown). Analysis 
of the forward steps on the contralateral side revealed a 
significant effect of the lesion on performance, but no 
overt recovery was evident from the rWGE or hWGE 
grafts [Group: F(3, 33) = 77.33, p < 0.001; Control vs. 
Lesion, rWGE, hWGE, all p < 0.001] (Fig. 2G). Overall, 
there was also a reduction in the number of adjusting steps 
during the postgraft test phase, relative to the postlesion 
phase [Time: F(1, 33) = 36.26, p < 0.001].
No effect of striatal lesion was evident on the back-
ward steps using the contralateral paw, nor any effect of 
the grafts [Group: F(3, 33) = 1.13, n.s.].
To investigate further the change in performance over 
time, we compared postgraft performance to the postlesion 
baseline. Results revealed a significant reduction in the 
number of forward adjusting steps for Lesion and rWGE 
graft groups, which was not evident in the Control or hWGE-
grafted rats [t(6) = −5.27 and t(10) = −6.61, both p < 0.01, 
Lesion and rWGE, respectively; Control and hWGE, n.s.].
Correlations. Interestingly, no significant correlations 
were evident between total P-zone or total graft volume, 
and performance on any of the behavioral tasks at week 
20 (data not shown). However, an expected correlation 
was found between P-zone volume and graft volume 
(r = 1.000, n = 21, p < 0.000).
DISCUSSION
The aim of this study was to compare directly the func-
tional efficacy of rWGE and hWGE grafts on tasks of 
motor function to determine whether clinically relevant 
hWGE grafts alleviated motor impairments to the same 
extent as the gold standard rWGE grafts. The data reveal 
subtle but comparable improvements in behavioral per-
formance in rats grafted with rWGE and hWGE primary 
tissue, despite significant differences in the total volume 
of surviving graft tissue. The implications of these results 
are discussed in greater detail below.
Immunohistochemical Analysis of rWGE 
and hWGE Grafts
Although postmortem immunohistochemical exami-
nation verified the survival of intrastriatal grafts in 
each cohort up to 21 weeks, differences in the volume 
of surviving graft tissue was evident. rWGE grafts were 
of a modest size, surviving within the degenerated lat-
eral neostriatum of the host brain, but not demonstrating 
complete replacement of all the lesioned tissue. In con-
trast, hWGE grafts were of significantly larger volume, 
filling the lesioned area. Both rWGE and hWGE grafts 
presented with DARPP-32-positive P-zones, which indi-
cates replacement of the appropriate GABAergic medium 
spiny neurons within the degenerated brain, although the 
proportions of P-zones, relative to the total graft vol-
ume, were greater in the rWGE grafts. Moreover, clear 
indication of circuitry reconstruction was evident in the 
innervation of tyrosine hydroxylase-positive projections 
from the substantia nigra onto the grafted rat and human 
fetal neurons.
Impact of rWGE and hWGE Grafts on 
Behavioral Performance
Apomorphine-Induced Rotational Bias. The apomor-
phine-induced rotational bias test is used as a simple and 
robust measure to reveal the loss of GABAergic medium 
spiny neurons in the striatum and the effect of any 
FACING PAGE
Figure 2. Behavioral impact of rWGE and hWGE grafts. Raw data showing performance of Control, Lesion, rWGE, and hWGE 
cohorts on apomorphine-induced rotational bias (A), cylinder test (B), staircase test (C), vibrissae-evoked forepaw placing test 
(E), and adjusting steps test (G). Data are also represented as the percentage change, relative to the baseline (postlesion) phase for 
staircase (D), vibrissae-evoked forepaw placing test (F), and adjusting steps test (H). **p £ 0.01 for Lesion versus rWGE and hWGE 
comparisons. $p £ 0.05, $$$p £ 0.001 for Control versus any experimental groups. £p £ 0.05 for effect of time (postlesion vs. postgraft 
comparisons). #p £ 0.05 for comparisons to baseline performance (100%).
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restorative intervention on effective striatal reconstruc-
tion. Previous studies have reported mixed results, with 
evidence of recovery after the grafting of E15 WGE but 
only in animals that received targeted behavioral training 
(10); E14 from the lateral, but not whole or medial, GE 
(26,37); and E13, but not E14 or E15, WGE grafts (33). 
To date, the only behavioral recovery reported using human-
derived GE grafts has utilized apomorphine-induced rota-
tions to assess functionality (28,32). In the present study, 
recovery was induced in rats grafted with E14 rWGE and 
hWGE, at all (15–21 weeks) postgraft time points. The 
magnitude of recovery was also comparable between 
rWGE and hWGE grafts, despite differences in graft vol-
ume. Interestingly, apomorphine-induced rotations have 
also been effective in revealing the functional efficacy of 
human stem cell-derived neuronal cells in rodent models 
of HD (6,36).
Of note is the increase in rotations observed across all 
lesioned groups at the postgraft stage relative to the postle-
sion stage. This increase could be explained by an inter-
action between cyclosporine and apomorphine activity. 
Since cyclosporine inhibits CYP3A4 and P-glycoprotein, 
and apomorphine is a substrate of these, the net result is 
increased plasma levels of apomorphine when admin-
istered alongside cyclosporine, leading to the increased 
rotational bias effect.
Cylinder Test. The cylinder test was utilized in the 
present study based on previous evidence that rWGE 
graft-mediated improvements have been observed using 
this task with E15 and E13 WGE transplants (8,33). In 
this study, however, the behavioral impact of the lesion 
was not sufficient to allow investigation of any impact of 
the rWGE or hWGE graft interventions.
Staircase Test. It is well established that rWGE grafts 
are capable of alleviating gross motor impairments 
(9,10) and improving fine motor control (22). The most 
frequently reported improvements are observed on the 
staircase test, although it is well established that exten-
sive training and relearning to use the graft are essential 
prerequisites to observing graft-mediated recovery. It has 
been reported that grafts derived from both E14 and E15 
WGE are capable of improving skilled paw-reaching 
ability in the staircase test (8,9,10,13) and that the extent 
of recovery depends upon the proportion of DARPP-
32-positive P-zones present (25). However, recovery on 
this task has not always been consistent. Where a lack 
of graft-mediated recovery has been observed in paw 
reaching, the inclusion of an environmental enrichment 
manipulation has been necessary to improve perfor-
mance (7). In other circumstances, the E14 medial GE 
has been found to induce recovery more effectively than 
the E14 WGE or lateral GE (37). Occasionally, no graft-
mediated recovery is evident on this task (38). The lack 
of improvement observed in our data set may relate to 
unidentified differences in graft composition or integra-
tion. The effect of daily cyclosporine on recovery of 
performance is not well understood and should be con-
sidered, although despite the immunosuppression regi-
men, all rats did continue to respond vigorously in the 
task each day. Alternatively, it may be explained by the 
reduced volume of rWGE grafts, although despite their 
greater volume, hWGE grafts also failed to improve 
paw-reaching performance.
Vibrissae-Evoked Forepaw Placing Test. The vibris-
sae-evoked forepaw placing test is a test of spontaneous 
sensorimotor function that is used fairly infrequently in 
the context of HD but which has previously revealed the 
functional efficacy of viable grafted cells. For example, 
Klein and colleagues (22) demonstrated recovery of 
motor function using the vibrissae test after transplanta-
tion of E15 WGE grafts into a rat model of HD. Our study 
further supports these results by revealing improvement 
in spontaneous reaching after vibrissae stimulation both 
in rats grafted with rWGE and hWGE tissue.
Adjusting Steps Test. Previous studies have reported 
improved performance on the adjusting steps test after 
transplantation of E15 WGE (8), although a lack of 
recovery has also been reported using the same tissue 
source (22). Similar to Klein et al. (24), we observed a 
decrease in stepping behavior over time in lesioned rats. 
Interestingly, however, while rats grafted with rWGE 
also demonstrated a decrease in adjusting steps between 
the postlesion and postgraft test phases, rats grafted with 
hWGE maintained a stable level of performance between 
the testing time points. Although this stabilization of 
behavior does not amount to improved performance per 
se, it is noteworthy that data gathered from clinical trials 
with patients with HD has often revealed a stabilization of 
behavior in grafted patients, relative to the deterioration 
observed in ungrafted control patients (4,20,31). That is, 
patients’ performance on a task is maintained and does 
not demonstrate the natural decline observed in ungrafted 
patients. Thus, these preclinical results may parallel those 
observed clinically.
hWGE in Preclinical Studies
Few preclinical studies have investigated the func-
tional efficacy of human-derived GE grafts. Several 
studies report the cellular profiles of hWGE grafts, dem-
onstrating medium spiny neuron maturation and noting 
that the percentage of P-zone formation is less in hWGE 
than in rWGE grafts (17,28). Human striatal grafts have 
also been shown to form long efferent and afferent con-
nections with the host brain (5,21,28,39). However, 
behaviorally, only two papers report recovery of function 
posttransplantation of hWGE. Pundt et al. (28) report a 
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reduction in apomorphine-induced rotation starting from 
50 days posttransplant after intrastriatal transplanta-
tion of WGE from a fetus measuring 110 mm, which is 
equivalent to 14 weeks gestation. Similarly, human fetal 
tissue of 7–9 weeks postconception was found to reduce 
apomorphine-induced rotational bias as early as 1 month 
postgraft (32). Thus, the data presented here represent 
the first comprehensive investigation of the functional 
efficacy of hWGE grafts. Our data support the previous 
literature on hWGE grafts and apomorphine rotations 
and extend our knowledge by demonstrating effects on 
vibrissae-evoked touching and adjusting steps.
Although not directly tested here, the review of the 
preclinical literature raises questions as to the optimal 
cells necessary for behavioral recovery. The WGE, which 
consists of medial GE containing interneurons and lateral 
GE, is the most frequently investigated source of tissue. 
However, it is not clear to what extent the medial GE is 
necessary to support the medium spiny neurons arising 
from the WGE. Conflicting results have been obtained, 
for example, using the staircase test in which the pro-
portion of DARPP32-positive cells has been reported 
to correlate with behavioral recovery (25), while others 
observe relatively more recovery using medial GE than 
lateral GE or WGE (37). It will be critical to address 
such questions as the field progresses toward the effec-
tive development of ES-derived medium spiny neurons 
for transplantation.
hWGE in Clinical Studies
Most clinical studies conducted thus far have endeav-
ored to test the safety and feasibility of grafting hWGE 
tissue into patients and to establish the optimal param-
eters for clinical application of this therapeutic interven-
tion. Where assessment of the functional efficacy of the 
grafts has been undertaken, interesting results have so far 
been obtained. For example, Hauser et al. (20) reported 
a transient and mild stabilization of motor scores on the 
UHDRS at 12 months posttransplant using LGE harvested 
from fetuses of 8–9 weeks postconception. Patients in the 
mild-moderate stages of disease grafted with tissue from 
fetuses of 8–12 weeks postconception also demonstrated 
a slowed progression of the disease in the early stages, 
despite no long-term improvement (up to 10 years) in 
the grafted group relative to a control, ungrafted cohort 
(4,31). The authors suggest that too few cells were grafted 
to provide sufficient clinical benefit.
Importantly, however, Bachoud-Levi and colleagues 
(1,2) observed improvements in motor and cognitive 
functions up to 2 years postgraft, followed by stabili-
zation for a further 4 years on tasks of motor function 
and for 6 years on cognitive tasks in a subset of grafted 
patients. Similarly, it has been shown that that one out 
of two patients showed increased striatal D2 receptor 
binding on the PET scan and demonstrated sustained 
clinical improvement up to 5 years postgraft (30).
rWGE Versus hWGE Grafts
Previous studies utilizing hWGE have only reported 
functional efficacy in vivo using the apomorphine rota-
tion task, while an abundance of studies have reported 
improvements in a range of motor tests, as well as 
enhanced cognitive function, after grafting of rWGE. 
Interestingly, our data suggest comparable improvements 
on the apomorphine rotation test and vibrissae task in 
both graft groups, but only hWGE stabilized performance 
on the adjusting steps test.
Fundamental differences exist in the development of 
the striatum of the rat and the human, which will undoubt-
edly impact upon the rates of maturation and integration 
of these ganglionic eminence grafts. For example, the pro-
portion of P-zone volume in rWGE grafts has been found 
to be greater than that observed in hWGE grafts (18), 
and the maturation of hWGE grafts is slower than rWGE 
(17,18,23). Thus, the optimal stage for utilizing hWGE 
for functional recovery still remains to be definitively 
determined and the effect of differing maturation profiles 
on functional efficacy is not yet well understood.
CONCLUSION
The data presented here confirm the ability of rWGE 
grafts to reduce rotational bias and improve sensorimotor 
function in the vibrissae task, but in contrast, no improve-
ments in paw reaching were observed on the staircase task, 
despite clear effects of the lesion on performance for all 
groups. Interestingly, we observed similar recovery in 
rats grafted with hWGE, with the additional benefit of the 
hWGE grafts maintaining performance on the adjusting 
steps test. These data are, to our knowledge, the first direct 
comparison of rWGE and hWGE grafts on motor function, 
as well as the first comprehensive, preclinical investiga-
tion into the functional efficacy of hWGE. While further 
investigation into the ability of these cells to improve cog-
nitive functions is warranted, the results presented here 
support the continued evaluation of this cell source (along-
side other pluripotent stem cells) for clinical translation to 
develop novel cell therapies that can stabilize or alleviate 
motor impairments in people with HD.
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